Word: cancerously
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...maker of the RFID chips used in the program, VeriChip Corporation, a subsidiary of the Delray Beach-based Applied Digital Solutions, is funding the initiative and wants to market its tags to the roughly 45 million high-risk patients in the U.S. with diseases such as Alzheimer's, diabetes, cancer and heart disease. The company says these patients can benefit from having instant and accurate access to medical records, which the chip would provide. "The medical community understands the need for a comprehensive electronic medical record that has portability," says VeriChip Chairman and CEO Scott Silverman. "What goes...
...special screening of his 2005 directorial debut, “The Lost City.” The screening was part of a Harvard Foundation for Intercultural and Race Relations tribute to Garcia for his humanitarian work. Garcia has worked on behalf of hurricane victims, at-risk youth, and cancer patients during his career. The foundation’s director, S. Allen Counter, said Garcia was a natural choice for the honor. “Andy Garcia is very much respected by Cuban-American students for his support for democracy and freedom in Cuba and merging those ideas with the arts...
...Tagliaferri and Cohen left Buck to establish Bionovo, where they began Phase II trials of BZL101 in April 2006, expanding their studies to 10 hospitals and breast cancer centers, including the University of Chicago Medical Center, Duke University Medical Center and the M.D. Anderson Cancer Center in Houston. Bionovo expects the second phase of trials to conclude by early...
Women with breast cancer have typically sought Chinese medical herbalists for relief from the side effects of chemotherapy and radiation or to strengthen and balance their immune systems; some have even hoped for a cure. Some women may have been helped; others not. But with so many variables - the broad range of patients, quality and potency of the herbs available, types of formulations prescribed and the expertise of the herbalist - outcomes in informal settings were never a sure thing. And it's the same kind of variability that has made clinical research so problematic. "Even though people are very interested...
...least is eager to see more studies of botanical treatments of cancer. "We're not opposed to Chinese medicine," says Dr. Shaw Chen, botanical review team leader at the FDA. "We just like to see clinical studies that meet our standards." Chen agrees it can be tough to study the pharmacological activity of botanical compounds or to ensure consistency in quality, but Bionovo's efforts, if fruitful, may help pave the way for other research. "A successful application to market for a cancer drug based on Chinese medicine will be encouragement to the industry," he says. "I think the industry...